Open a VIP account (an enterprise account with priority handling, 24/7 dedicated customer care, unlimited usage/users, help on formatting, standards, rules, regulations, policy compliance, etc., and ...
Roche has announced U.S. FDA approval of Enspryng (satralizumab) for adults with thyroid eye disease, describing it as the first at-home subcutaneous option for the condition. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results